<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00866424</url>
  </required_header>
  <id_info>
    <org_study_id>20080327-1</org_study_id>
    <nct_id>NCT00866424</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients</brief_title>
  <official_title>A Prospective Study on Efficacy of Hyperbaric Oxygenation Treatment for Patients With Trigeminal Neuralgia: a Randomized, Double-Blind, Mock Hyperbaric Chamber -Controlled, Parallel-Group Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the hyperbaric oxygen treatment reduces&#xD;
      pain and improve the life quality in trigeminal neuralgia patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trigeminal neuralgia(TN) is a recurrent severe shooting neuropathic pain. Treatment of this&#xD;
      pain continues to be a challenge in clinical pain management. Hyperbaric oxygen (HBO) has&#xD;
      been used of neuropathic diseases, which can improve blood partial pressure of oxygen, reduce&#xD;
      edema, relieve neural oppression and attenuate inflammatory response. The hypothesis of this&#xD;
      protocol is that hyperbaric oxygen treatment could relieve neuropathic pain and improve the&#xD;
      quality of life in TN patients. Visual analogue scale (VAS) and the mcgill pain questionnaire&#xD;
      (MGPQ) will be assessed before the initiation of the study, after hyperbaric oxygen (HBO)&#xD;
      treatment and at monthly intervals for the subsequent 3 months. Titration of dosage and pain&#xD;
      frequency will be recorded throughout the study. Clinical global impression (CGI) by the&#xD;
      individual patient will be evaluated at monthly intervals after HBO treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">April 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue scales (VAS), the mcgill pain questionnaire (MGPQ).</measure>
    <time_frame>after HBO treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analogue scales (VAS), the mcgill pain questionnaire (MGPQ),pain frequency, titration of dosage, clinical global impression (CGI)</measure>
    <time_frame>at monthly intervals for the subsequent 6 after hyperbaric oxygen (HBO) treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Trigeminal Neuralgia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>A,2, II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperbaric oxygen, Mock hyperbaric chamber</intervention_name>
    <description>Hyperbaric oxygen treatment for 10 days in treatment groups and mock hyperbaric chamber treatment for 10 days in control groups.&#xD;
Hyperbaric oxygen treatment: While in the hyperbaric chamber the subjects breathe 100% oxygen saturation with mask at 2.0bars.&#xD;
Mock hyperbaric chamber treatment: The subjects breathe air freely in the imitation environment chamber at 1.0bars.</description>
    <arm_group_label>A,2, II</arm_group_label>
    <other_name>the delivery of oxygen in a pressurised chamber</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-70&#xD;
&#xD;
          2. Primary TN patient (MRI examination support diagnosis)&#xD;
&#xD;
          3. Suffering from this pain for at least 3 months&#xD;
&#xD;
          4. VASï¹¥40mm&#xD;
&#xD;
          5. Patient can assess pain intensity correctly&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Undergone surgery for TN(including nerve injections) within the last year&#xD;
&#xD;
          2. Oral medicine change within the last week&#xD;
&#xD;
          3. With other diseases of nervous system&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li ze Xiong, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Xijing Hospital, Fourth Military, Medical Univercity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an,</city>
        <state>Shaanxi</state>
        <zip>086</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <study_first_submitted>January 14, 2009</study_first_submitted>
  <study_first_submitted_qc>March 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2009</study_first_posted>
  <last_update_submitted>March 19, 2009</last_update_submitted>
  <last_update_submitted_qc>March 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lize Xiong/A Prospective Study on Efficacy of Hyperbaric Oxygenation Treatment for Patients with Trigeminal Neuralgia: a Randomized, Double-blind, Mock hyperbaric Chamber -Controlled, Parallel-Group Trial</name_title>
    <organization>Fourth Military Medical University</organization>
  </responsible_party>
  <keyword>trigeminal neuralgia</keyword>
  <keyword>pain</keyword>
  <keyword>HBO</keyword>
  <keyword>VAS</keyword>
  <keyword>MGPQ</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigeminal Neuralgia</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

